Works matching IS 10837159 AND DT 2015 AND VI 20 AND IP 3
Results: 20
Challenges of Efficacy Assessments in Pseudomyxoma Peritonea.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 243, doi. 10.1634/theoncologist.2014-0400
- By:
- Publication type:
- Article
TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 263, doi. 10.1634/theoncologist.2014-0391
- By:
- Publication type:
- Article
Phase I Study of Cisplatin, Hyperthermia, and Lapatinib in Patients With Recurrent Carcinoma of the Uterine Cervix in a Previously Irradiated Area.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 241, doi. 10.1634/theoncologist.2014-0365
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. e5, doi. 10.1634/theoncologist.2014-423
- By:
- Publication type:
- Article
Phase I Dose-Escalation Study of Pilaralisib (SAR245408, XL147), a Pan-Class I PI3K Inhibitor, in CombinationWith Erlotinib in Patients With Solid Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 245, doi. 10.1634/theoncologist.2014-0449
- By:
- Publication type:
- Article
M1 Stage Subdivision and Treatment Outcome of Patients With Bone-Only Metastasis of Nasopharyngeal Carcinoma.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 291, doi. 10.1634/theoncologist.2014-0206
- By:
- Publication type:
- Article
A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 239, doi. 10.1634/theoncologist.2014-0326
- By:
- Publication type:
- Article
Progestins in the Fertility-Sparing Treatment and Retreatment of Patients With Primary and Recurrent Endometrial Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 270, doi. 10.1634/theoncologist.2013-0445
- By:
- Publication type:
- Article
Helical Tomotherapy in Head and Neck Cancer: A European Single-Center Experience.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 279, doi. 10.1634/theoncologist.2014-0337
- By:
- Publication type:
- Article
Prostate-Specific Antigen Testing: Good or Bad?
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 233, doi. 10.1634/theoncologist.2015-0019
- By:
- Publication type:
- Article
Should FOLFOXIRI Plus Bevacizumab Be the Standard First-Line Therapy inMetastatic Colorectal Cancer?
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 236, doi. 10.1634/theoncologist.2014-0495
- By:
- Publication type:
- Article
The European Medicines Agency Review of Pomalidomide in CombinationWith Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee forMedicinal Products for Human Use.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 329, doi. 10.1634/theoncologist.2014-0073
- By:
- Publication type:
- Article
Complex Decisions for First-Line and Maintenance Treatment of Advanced Wild-Type Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 299, doi. 10.1634/theoncologist.2014-0212
- By:
- Publication type:
- Article
Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 323, doi. 10.1634/theoncologist.2014-0420
- By:
- Publication type:
- Article
Immunohistochemical Validation of Overexpressed Genes Identified by Global ExpressionMicroarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 247, doi. 10.1634/theoncologist.2014-0392
- By:
- Publication type:
- Article
The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 307, doi. 10.1634/theoncologist.2014-0285
- By:
- Publication type:
- Article
Challenges of Efficacy Assessments in Pseudomyxoma Peritonea.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 316, doi. 10.1634/theoncologist.2014-0389
- By:
- Publication type:
- Article
External Quality Assessment Unravels Interlaboratory Differences in Quality of RAS Testing for Anti-EGFR Therapy in Colorectal Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 257, doi. 10.1634/theoncologist.2014-0382
- By:
- Publication type:
- Article